PaxMedica Inc

NASDAQ:PXMD

3.38

+0.28 (+9.03%)

7:59:33 PM EDT: $3.13 -0.25 (-7.40%)

PaxMedica Inc Stock, NASDAQ:PXMD

303 South Broadway, Suite 125, Tarrytown, New York 10591

United States of America

Phone: +1.914.987.2876

Number of Employees: 2

http://www.paxmedica.com

Description

PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.